Relay Therapeutics
Focus: Relay Therapeutics is a Cambridge-based oncology biotech specializing in motion-based drug design, a proprietary platform targeting protein kinases and other oncology targets through structure-based computational approaches.
Profile data last refreshed 8h ago · AI intelligence enriched 2w ago
Open Jobs
13+5 this month
Growing — net +5 jobs in 30d
8 jobs added vs 3 removed. Steady team buildout.
Should You Work at Relay Therapeutics?
AI assessmentStrong fit for early-career researchers and strategists seeking deep platform expertise and clinical pipeline exposure, but requires tolerance for pre-commercial stage risk.
Why Work Here
- Differentiated technology platform (motion-based drug design) offers exposure to cutting-edge computational biology and structure-based drug discovery
Data completeness
2/9 — Limited
Company HealthStrong
Pipeline
Mid-stage
1 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Random assigned paradigm viewing order
AnxietyClinical Trials (1)
NCT04622527A Study to Assess Virtual Reality by Healthcare Providers: A Pilot Study
N/AHelp build intelligence for Relay Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.